VERONICA HUBER: Open Payments
NPI 1841753563 · SPRING HILL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 21 payments from 12 companies in 2025. Trend: 2023 $221 · 2024 $292 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $69 |
| Sage Therapeutics, LLC | 2 | $43 |
| Sumitomo Pharma America, Inc. | 3 | $43 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $39 |
| Organon LLC | 2 | $38 |
| Exeltis, USA Inc. | 2 | $34 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $34 |
| Supernus Pharmaceuticals, Inc. | 1 | $28 |
| MILLICENT US INC | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: Veozah, ZURZUVAE, MYFEMBREE, JOURNAVX, NEXPLANON, SLYND, Qelbree, INTRAROSA.
Industry payments across FL — which companies pay providers there.
